Autopsy report · NCT02606110

Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer

“PI decided no longer to pursue”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Eastern Regional Medical Center

Sponsor type

University, hospital or other

Conditions

Peripheral Neuropathy

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Study of the Anti-PD-1 Antibody Nivolumab in Combination With Dabrafenib and/or Trametinib
  “PI decided not to proceed” (85% match in meaning)
• Pre-post Spinal Popliteal Block
  “Retrospective study that the PI decided not to proceed with” (80% match in meaning)
• Sensory Habituation in Autism Spectrum Disorders
  “PI no longer at institution.” (78% match in meaning)
• Metabolic Abnormalities in Hispanic Children With Cystic Fibrosis
  “PI no longer with the University” (75% match in meaning)
• Novel Gallium 68 Citrate in Orthopedic Infections
  “PI left the institute and the funding expired.” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.